Maze Therapeutics MAZE
NASDAQ MAZE
$32.84 +0.39 (+1.20%)
As of: Oct 21, 2026 · 1:04 PM EDT

Maze Therapeutics (MAZE) Interest Coverage Ratio (2026)

Updated

Maze Therapeutics' (MAZE) Interest Coverage Ratio came in at -51.60 for Q2 2026.

Analysis

Maze Therapeutics (MAZE) Interest Coverage Ratio (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn -
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 25.41
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn -
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn -
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 10.28
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 7.27
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn 5.22
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn -42.08
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 Maze Therapeutics 1.93 Bn 445.16 Mn - -51.60
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.60
Mar 31, 2026 -30.66
API Access

Maze Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=MAZE&period=max&api_key=YOUR_API_KEY